Bronchiectasis. Northland 2013 - 10 known paediatric patients with bronchiectasis in Whangarei and 4 in greater Northland. Now 27 confirmed non cystic.

Slides:



Advertisements
Similar presentations
Definition of COPD COPD is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual.
Advertisements

Chest Infections Lawrence Pike.
GOLD MANAGEMENT PLAN FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
BY DR.Khaled Helmy Chest Specialist Al Mahmora Chest Hospital Ministry of Health - Egypt COPD SCOPE ON.
Infection in COPD Pulmonology Subspeciality Rounds (12/11/2008)Dr.Krock Dr.Vysetti Dr.Vysetti.
DR. SRINIVASAN. Goals of the lecture Definition of asthma & brief pathogenesis Initial diagnosis and ddx Factors that can trigger or aggrevate asthma.
Disorders of the respiratory system 2
Michael W. Nash, MD Family Medicine Clinton County Rural Health Clinic Understanding COPD.
THE UNIFIED AIRWAY A CPMC Regional CME Event - An Integrated Approach Saturday October 1, 2011.
4.5 Lung disease – fibrosis, asthma and emphysema.
Pneumonia in children including SARS Winnie Chu The Chinese University of Hong Kong Department of Diagnostic Radiology and Organ Imaging Prince of Wales.
Cystic Fibrosis Gina Brandl, RN BSN Nursing Instructor, Pediatrics.
Paediatric asthma Thorax 2003; 58 (Suppl I): i1-i92.
Pneumonia: nursing management Islamic University Nursing College.
Lesson 4 Care and Problems of the Respiratory System Respiratory system problems can affect the functioning of other body systems. Imagine not being able.
Professor of Respiratory Medicine
Approach To Broncheactaisis
Dr. Danny Galdermans Dept Respiratory Medicine ZNA Middelheim Antwerp
1 RETROSPECTIVE EVALUATION OF THE PATIENTS WITH CYSTIC FIBROSIS DR.LALE PULAT SEREN ZEYNEP KAMİL MATERNITY AND CHILDREN’S TRAINING AND RESEARCH HOSPITAL.
Applied Epidemiology Epidemiology of Chronic Obstructive Pulmonary Disease (COPD) By Chris Callan 23 April 2008.
Resident Report Bronchiectasis Irreversibly dilated peripheral airways secondary to chronic inflammation from a variety of causes Pathogenesis.
CHRONIC OBSTRUCTIVE PULMONARY DISEASE COPD Juliana Tambellini University of Pittsburgh.
Patient Empowerment in Chronic Obstructive Pulmonary Disease (COPD) Noreen Baxter Respiratory Nurse Specialist May 2005.
Management of Patients With Chronic Pulmonary Disease.
Chronic Obstructive Pulmonary Disease Natasha Chowdhury.
Definition of COPD COPD is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual.
By Taliyah and Selina. Cystic Fibrosis CF Mucoviscidosis.
The Child with Cystic Fibrosis Lydia Burland. Learning Outcomes By the end of the session you should;  Know the basic physiology underlying CF  Recognise.
Symptoms In newborns: – Delayed growth – Failure to gain weight normally during childhood – No bowel movements in first 24 to 48 hours of life – Salty-tasting.
22/06/2011.  Asthma – an introduction (Vanessa)  Diagnosis and management of chronic asthma in line with current BTS guidelines (Dr Lowery)  3 x Case.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student under Nephrology Division under the supervision and administration.
Dr Abdalla Elfateh Ibrahim Consultant and assistant Professor Of Pulmonary Medicine.
Bronchiectasis Sami ur Rahman Roll No: Overview Definition Etiology Pathology Clinical Presentation Diagnosis Treatment.
Bronchiectasis SS Visser, Pulmonology Internal Medicine UP.
Approach to bronchiectasis
Habib GHEDIRA, MD, Prof. Medical Faculty of Tunis
Respiratory Service Framework Asthma and COPD Care (Nursing) Project Learning and Development Strategy.
Lesson 4 Care and Problems of the Respiratory System Respiratory system problems can affect the functioning of other body systems. Imagine not being able.
By Dalia Munoz ASTHMA. is a serious and ongoing disease that affects the airways of both adults and children. Airways are the tubes that carry air in.
Approach To Pneumonia. Pneumonia Importance Mechanism Classification & its benefit Diagnosis Treatment.
NURS 171 RESPIRATORY SYSTEM: PNEUMONIA Darlene LoPresto, Graduate Student FSU.
Bronchitis By Leyre Poza and Marilyn Quintana. Content What's bronchitis? Causes Symptoms Transmission Types Prevention I Treatment II Treatment Bibliography.
Respiratory care.
GOLD Update 2011 Rabab A. El Wahsh, MD. Lecturer of Chest Diseases and Tuberculosis Minoufiya University REVISED 2011.
New Strategies of the EPR-3. – Asthma is a chronic inflammatory disorder of the airways – The immunohistopathologic features of asthma include inflammatory.
COPD Diagnosis & Management Anil Ramineni Specialist Respiratory Physiotherapist Community Respiratory Team.
PHL 437/Pharmacogenomics First Lecture (Asthma I) By Abdelkader Ashour, Ph.D. Phone:
Bronchial asthma By Dr. Abdelaty Shawky Assistant professor of pathology.
Chronic Obstructive Pulmonary Disease Austin Paul K.
Integrated Management of Childhood Illnesses
COPD ) ) Chronic Obstructive Pulmonary Disease. Introduction n COPD is a preventable and treatable disease with some significant extrapulmonary effects.
Bronchiolitis Abdullah M. Al-Olayan MBBS, SBP, ABP. Assistant Professor of Pediatrics. Pediatric Pulmonologist.
Management of Patients With Chronic Pulmonary Disease
Summary The National Clinical Pathway represents a pathway that is achievable now, requiring no extra resources but reliant on appropriate logistics. The.
 Wheezing illnesses other than asthma in children.
Protracted Bacterial Bronchitis (PBB) The Bronchoscopy Findings
Management of stable chronic obstructive pulmonary disease (2) Seminar Training Primary Care Asthma + COPD D.Anan Esmail.
Chronic Obstructive Pulmonary Disease Clinacal Pharmacy.
National Clinical Pathway for suspected and confirmed lung cancer:
Risk for development of bronchiectasis in patients with Protracted Bacterial Bronchitis Danielle WURZEL1, Julie M MARCHANT1, I Brent MASTERS1, Stephanie.
Addition of Inhaled Tobramycin to Ciprofloxacin for Acute Exacerbations of Pseudomonas aeruginosa Infection in Adult Bronchiectasis* Diana Bilton, MD;
Diseases of the respiratory system lecture 3
Greater Glasgow Outreach Spirometry Service: A model for closer collaboration between primary and secondary care and its impact on chronic lung disease.
COPD Dr MAMATHA SARTHI GPST3.
Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable and treatable disease that is characterized by persistent respiratory symptoms and.
Lower respiratory infections
Brown SMN1,2, Bush A1,2, Davies JC1,2, Thursfield R1,2, Lloyd CM1
Dr R Nadama MD MRCP(lond) MRCP(UK), FRCP(Lond), EDARM, FCCP
How will the NHS Long Term Plan work in our community?
Dr R Nadama MD MRCP(lond) MRCP(UK), FRCP(Lond), EDARM, FCCP
Presentation transcript:

Bronchiectasis

Northland known paediatric patients with bronchiectasis in Whangarei and 4 in greater Northland. Now 27 confirmed non cystic fibrosis bronchiectatic patients in Northland

Early and effective management reduces short- and long-term morbidity

Definition Irreversible bronchial dilatation Radiological or pathological diagnosis HRCT scan current gold standard

Chronic Suppurative Lung Disease Symptoms of chronic endobronchial suppuration +/- radiological evidence of bronchiectasis

Chronic infective bronchitis Protracted bacterial bronchitis Prolonged wet cough Resolves completely after treatment If untreated may progress to bronchiectasis

Bx, CSLD, Protracted bacterial bronchitis Symptoms and signs overlap and lack specificity Absolute reliance on radiology-based definition unsatisfactory –When to do imaging –Age related changes in bronchoarterial ratio uncertainty –2 HRCT scans to fulfil irreversible defn –Influence of acute illness

Definitions ?chronic suppurative lung disease best overarching term

Pathogenesis Obstruction Chronic inflammation, progressive wall damage, dilatation Abnormal cartilage formation (congenital causes) Common thread: difficulty clearing secretions + recurrent infections Resulting airway injury and remodelling

Pathogenesis 2 Infections and an ineffective host immune response involving uncontrolled recruitment and activation of inflammatory cells within lower airways Release of mediators, eg proteases and free radicals Causing bronchial-wall injury and dilatation

Causes (paeds) Congenital CF Immune deficiency Primary ciliary dyskinesia Aspiration, recurrent small volume Post-infection (Systemic inflammatory diseases)

Investigations FBC Immunoglobins Sweat test Sputum PCD – exhaled fractional nasal nitric oxide and/or nasal ciliary brushings Spirometry and lung volumes (>6yo)

Invx additional CF gene mutations Bronchoscopy – FB/ airway abnormality Ba swallow/ video fluoroscopy Further immune tests –IgE, neut fnc test, lymphocyte subsets, ab resp to vaccinations HIV Echo (esp adults, ?pulm hypertension)

Assessment of severity 1 Clinical –Cough –Sputum –Exacerbation rate –Well-being

Assessment Severity 2 Lung function Spirometry –Classically obstructive –Repeated at each review –Relatively insensitive in mild disease, and in children –Spirometric volumes can stabilize and improve in children 6 minute walk –Assessment functional impairment

Microbiology Common pathogens children: –H influenzae –S pneumoniae –M catarrhalis

Management Early and effective mgmt reduces short- and long-term morbidity

Management 1 Airway clearance Chest physiotherapy Nutrition Fitness and activity Avoidance of environmental pollutants –TOBACCO Assessment for co-morbidities Annual ‘flu immunisation

Management 2 Intensive antibiotic treatments –Reduce microbial load –Oral Abx and ambulatory care initially –Hospital and IV Abx + intensified physio more severe/ unresponsive oral

Burden of disease Incidence – non-CF Bx/CSLD NZ <15yo 3.7/ per year (2x CF incidence) Central Australian Indigenous children 1470/ /year US yo 4.2/

Northland burden

Northland 27 children 0-16 Almost all post-infection x1 with unsafe swallow x1 with IgA deficiency 2 other children with PCD but not Bx

Paediatric Bronchiectasis Clinic Quarterly multidisciplinary clinic Currently only at Whangarei Physio, nurse, doctor Team meeting at the conclusion of each clinic to discuss patient’s plans and monitoring and discussion of issues. Same physiotherapist in clinic as on ward –aids with continuity of care –outreach nurse also follows patient both in the community and on admissions.

Aims of Multidisciplinary clinic: To provide standardised care to children with bronchiectasis To provide ongoing monitoring in accordance with guidelines for bronchiectasis To prevent/reduce hospital admissions To provide a continuum of physiotherapy techniques in the management of bronchiectasis through their childhood

Aims of Multidisciplinary clinic To develop a proactive application to deliver health care for these children and their families to reduce disease progression To provide education and promotion of healthy lifestyles for families with the aim of reducing disease progression To provide a central point of contact for patients and family with bronchiectasis and thus patient centred care To provide holistic care To reduce inequalities of health care access

Presentation Chronic or recurrent wet cough Children do not usually expectorate Cough often temporarily resolves after treatment

Primary care input 1 Index of suspicion –Two or more episodes of chronic (>4 wks) wet cough/year that respond to Abx –CXR abnormalities persisting at least 6 wks after appropriate therapy Specialist referral

Primary care input 2 Management of exacerbations –Appropriate antibiotic for patient –Appropriate length of course –Low threshold for referral for admission if not improving Routine immunisations, plus annual ‘flu Smoking cessation advice and support

Questions?